A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Sudden Changes in the ALSFRS-R in Three ALS Clinical Trials
Poster, European Network for the Cure of ALS (ENCALS), 2022
Shefner JM, et al
Edinburgh, UK
June 1, 2022
Aficamten, a Selective Small-Molecule Cardiac Myosin Inhibitor for the Potential Treatment of Hypertrophic Cardiomyopathy
Poster, Gordon Research Conference: Cardiac Regulatory Mechanisms, 2022
Sarkar SS, et al
New London, NH
June 26, 2022
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction The METEORIC-HF Randomized Clinical Trial
Journal of the American Medical Association
Lewis GD, et al
July 19, 2022
Early Cardiac Structural and Functional Reverse Remodeling in Obstructive Hypertrophic Cardiomyopathy after 10 Weeks of Aficamten Therapy: Analyses from REDWOOD-HCM
Poster, American Society of Echocardiography 2022
Abraham T, et al
Seattle, WA
June 11, 2022
Effects of Omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
European Heart Journal
Metra M, et al
May 22, 2022